L & G, First of all, I want to thank all the moderators

New Post Public Reply Private Reply Replies (3) Message Board
TechGuru HCIT #29401
718
L & G,

First of all, I want to thank all the moderators of this board. There is a lot of work involved in maintaining it and, they don’t have to do it, don’t receive anything and, honestly, the results speak by themselves.

There is no pun on this.

I personally have profited immensely from the work of all and kudos have to go to the moderators.

In the good old days several years back when the price was collapsing all the way to $0.29 and my account was swimming in red I always asked myself if I was crazy by keep on buying, I do my own DD but I am just smart enough to understand that I might be wrong as well; there were many sleepless nights and liters of coffee involved. However, this board kept me in the right path. Those who shared their insights (positive or negative) gave me information that otherwise I would have never had access to, or tough of, that helped to make the right decision: keep on buying.

So, literally I own you. Tarding, Misiu, Zuess421 Sjacobs26 ClosetInvestor LongPennyPincher Shelly2626, CDiddy and other moderators (I am sure I am forgetting somebody) thank you very much !!!

Unfortunately, our country is VERY polarized, the very nature of democracy is to have different opinions. This have accentuated as of late (several administrations) to the point that we have lost the sense of purpose and direction (I am blaming everybody here). While we fight among ourselves other countries are taking long strides towards the wellbeing of their citizens. As an example, China has now almost as many companies in the global Fortune 500 as the USA (119 vs 121) and the four largest banks are Chinese, we only have 2 in the first 10 with J.PMorgan chase showing as number 6. In researching medical/scientific papers, the Chinese are rapidly approaching the quality and quantity of our research and their companies will soon follow with products.

Is China at fault ??? No, we are. We need to get our act together and start advancing in the same direction instead of pulling all over the place and blaming others than ourselves.

The same can be said of our board. We all have our political opinions, however this does not mean that whatever a person says about Leronlimab’s science is wrong because he/she thinks differently about how we should go about advancing.

And there is the truth that cannot be compromised as otherwise we will be all lost.

So, instead of shooting ourselves in the foot, let’s keep working together sharing out research and opinions (about Leronlimab) and trying not to inject our political philosophies in the conversation. Not easy, but can be done.

We will all benefit at the end …
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

New Leadership at Bottle Rocket: Tom Bateman Steps In

Updated Category News Views 46

An Unexpected Move in Digital Product Leadership You know, just when you think the digital realm can't throw another card down, Bottle Rocket pulls out something from its hat by snapping up Tom Bateman. This fella's got three solid decades of experience under his belt, working his magic on digital product and experience gigs for the Fortune 500 gang. Now, that's no walk...

Continue Reading
Ambient AI Shows Promise for Boosting Cancer Care Efficiency

Updated Category News Views 97

Study Points to Ambient AI's Promise in Oncology Some days, the world of cancer care is a real beast to tackle. But today, we've got a glimpse into how technology, and specifically ambient AI, might just help slay some of the burdens that these healthcare warriors face daily. The Florida Cancer Specialists & Research Institute (FCS) joined hands to dive into how this tech...

Continue Reading
Endava Class Action: Investor Concerns Unveiled

Updated Category News Views 72

What's Happened with Endava? Endava plc, trading under NYSE:DAVA, just got pummeled. A lawsuit is making waves, targeting investors who bought into Endava between September 2025 and 2026. What's the fuss about? Their stock tanked 25% on September 22, 2026, following an unsettling revelation: the company disclosed serious management and potential accounting problems. A...

Continue Reading
Netcapital's 28.62% Plunge: A Fraudulent Drama Unfolds

Updated Category News Views 82

Netcapital: The Plunge Heard 'Round the Market There it is, clear as day—Netcapital’s (NASDAQ: NCPL) stock plummeting 28.62% like a lead balloon. Shareholders had to watch in horror as pieces of their investments seemed to evaporate, all thanks to a swirl of alleged fraud. You can't just shrug off accusations that a company you've betted on has been cooking its books,...

Continue Reading
Fair Play in Focus: SYNA, CSR, VCTR, EFSI Deals Scrutinized

Updated Category News Views 77

The Corporate Buzz: Deals Under the Microscope Riding the rollercoaster of mergers and acquisitions ain't new in the stock market realm. But when the stakes seem one-sided, alarms start ringing. Halper Sadeh LLC, a firm that cuts its teeth on this kind of corporate sleuthing, is all hands on deck probing a slew of big deals involving Synaptics (NASDAQ:SYNA), Centerspace...

Continue Reading
SurgeONE's Avery Actions: Pioneering AI in Compliance

Updated Category News Views 140

Revolutionizing Compliance with Avery Actions A brand spanking new player has stepped onto the compliance stage, and it's swinging a pretty big AI bat. SurgeONE.ai unveiled Avery Actions, an industry-first agentic AI platform that's aiming to wrangle all your compliance, cybersecurity, and data governance operations under one interoperable umbrella. It's a bold move, and...

Continue Reading
Utopia Bagels Honored at 2026 New York BagelFest

Updated Category News Views 125

From Queens Streets to Global Fame Try to picture this: a small neighborhood shop where the scent of freshly baked bagels wafts through, bringing together old friends and new generations. Now, take that local magic and multiply it by a global stage. That's the journey Utopia Bagels from Queens stepped into with massive strides over 45 years, earning a celebrated spot in...

Continue Reading
China's 15th Plan: Key Moves in the Capital Markets

Updated Category News Views 196

Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...

Continue Reading
Coastal Faces Legal Storm: Investors Eyeing the Clock

Updated Category News Views 85

Coastal Financial in the Crosshairs The stakes are big, folks. Coastal Financial Corporation (NASDAQ: CCB) is caught in a storm, and it's not a gentle breeze. A securities class action has hit the table, and it's drawing in investors like seagulls to a beach picnic. What Lit the Match? The story kicks off with a plummet so dramatic it turned heads and wallets upside...

Continue Reading
Epic Oceanside Estate Set for No-Reserve Luxury Auction

Updated Category News Views 66

Going, Going, Gone? A Golf Exec's Dream Home What's hotter than Florida's summer sun? It's this swanky estate at Ponte Vedra Beach set to hit the auction block without any safety net. Yup, no reserve, folks! Leonard "Len" Brown, Jr., the brains behind many of PGA Tour's global ventures, has decided to put his lavish 3.2-acre plot right by the ocean up for grabs. Once...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Unite on Semler Scientific Securities Class Action

Updated Category News Views 128

Understanding the Class Action Lawsuit Against Semler Scientific The Rosen Law Firm, known for advocating investors' rights, has initiated a class action lawsuit for purchasers of Semler Scientific, Inc. (NASDAQ: SMLR) securities. This lawsuit is centered around the time frame from March 10, 2021, to April 15, 2025. If you've invested in Semler Scientific during this...

Continue Reading
Antengene's 2025 Financial Results: Advances and Innovations

Updated Category News Views 136

Antengene Reports 2025 Interim Financial Achievements Antengene Corporation Limited (SEHK: 6996.HK) recently disclosed its interim financial results for the period concluding in mid-2025, underscoring significant strides within its clinical trials and innovative technologies. The report highlights noteworthy developments across their pipeline and promising data emerging...

Continue Reading
Complicated Urinary Tract Infection Market Growth on the Rise

Updated Category News Views 119

Complicated Urinary Tract Infections Market Outlook Complicated urinary tract infections (cUTIs) represent a significant challenge in the healthcare landscape. These infections can lead to severe complications if left untreated and are becoming increasingly prevalent due to factors such as antibiotic resistance and emerging bacteria. As a result, the cUTI market is...

Continue Reading
Kaiser Permanente Expands Everett Medical Center Services

Updated Category News Views 259

Enhanced Medical Services at Kaiser Permanente's Everett Center Kaiser Permanente has officially opened its newly expanded Everett Medical Center, significantly improving healthcare access and services for its members. This modern addition complements the existing facility and introduces a wide array of medical services across more than 20 specialties, ensuring...

Continue Reading
CenterPoint Energy and Technosylva Join Forces for Resilience

Updated Category News Views 146

Collaboration Between CenterPoint Energy and Technosylva CenterPoint Energy, a prominent player in the electric and natural gas utility sector, has embarked on an exciting collaboration with Technosylva, an expert in wildfire science and extreme weather risk mitigation. This partnership aims to utilize cutting-edge technologies such as artificial intelligence and...

Continue Reading